Clinical Trial: Impact of Secukinumab on Clinical and Patient Reported Outcomes in Patients With Psoriasis
Study Status: Completed
Recruit Status: Completed
Condition: Psoriasis
Study Type: Observational
Official Title: Impact of Secukinumab on Clinical and Patient Reported Outcomes in Patients With Psoriasis in a Real World Setting in the US (Bionaive Secukinumab Users NVS 521)
Brief Summary:
The study was conducted to describe the demographics, disease characteristics, disease severity, comorbidities and patient reported outcomes at baseline and follow-up periods among adult patients diagnosed with PsO in CorEvitas' PsO Registry under routine medical care initiating secukinumab (SEC).
Read more